AMGN - Amgen Inc

AMGN valuation $115.82 billion

Stock Price

152.26
Change: ↓ -4.11 (-2.6284%)
Last Update: 2015-01-30T16:15:05-05:00
Shares Outstanding: 760,670,000
Industry: Biotechnology
Website Investor Relations

The name of the company Amgen refers to Applied Molecular Genetics. Not only is it a multinational organization, it is also the world’s 3rd largest independent biotech company. In terms of growth and innovation, the company leaves behind all other organizations as it was ranked 1st by Business Week in the 500 most future oriented businesses. In Thousand Oaks, they remain the largest employer while in the Ventura County, the lead is only taken by the United States Navy.

In the last two decades, Amgen has acquired a number of different pharmaceutical corporations such as Synergen Inc., Kinetix Pharmaceuticals, Avidia Inc., BioVex Group, Inc., decode Genetics, Onyx Pharmaceuticals Inc. and some others.

Amgen’s products are used to tread serious diseases like cancer, kidney diseases, arthritis, etc. The first two products launched by Amgen turned out to be the most commercially successful biopharmaceutical products at that time which also established the company’s reputation of adapting the industry’s best manufacturing techniques. Those two products were called Epogen and Neupogen. Currently, the organization has a diversified product range and has introduced products such as Aranesp, Enbrel, Neulasta, Sensipar, Vectibix and Prolia. By the end of December 2011, the employee count in the company was reported as 17,800.

Stock Price Data

Open: 155.55 Previous Close: 156.37
High: 156.87 Low: 151.53
Bid: 152.16 Ask: 154.63

Bid Size: 100 Ask Size: 200
Raw Bid Size: 1 Raw Ask Size: 2
Trade Volume: 36486 Share Volume: 5087608
Last Trade Date: 2015-01-30 Last Trade Time: 16:15:03-05:00
Vwap: 152.9759231 EPS: 6.70

Fundamental Data

PE ratio: 23.10 PB ratio: 4.574
Beta: 0.552129

52 Week High: 173.14 52 Week Low: 108.20
52 Week High Vwap: 171.9081 52 Week Low Vwap: 107.5423
52 Week High Volume: 11626291 52 Week Low Volume: 1447029
52 Week Avg Volume: 3567575

Dividend Data

Dividend: 0.79 Date: 2015-02-10
Amount: 3.16 Yield: 2.021
Frequency: Q Paydate: 2015-03-06
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GILD Gilead Sciences Inc. 104.83
IMGN ImmunoGen Inc. 7.63
CELG Celgene Corporation 119.10
MNKD MannKind Corporation 6.35
ARNA Arena Pharmaceuticals Inc. 4.30
NVAX Novavax Inc. 7.81
NPSP NPS Pharmaceuticals Inc. 45.86
BIIB Biogen Idec Inc. 388.77
ARIA ARIAD Pharmaceuticals Inc. 6.45
PDLI PDL BioPharma Inc. 7.29